Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2014


Social Media in the Pharmaceutical Industry

22 Jan 2014 - 23 Jan 2014 - London, UK



Bookmark and Share


SMi is pleased to present the 6th instalment in the sell out Social Media Pharmaceutical conference series which returns to London on 22nd and 23rd January 2014.

With health at the top of any patient’s agenda the opportunity for health professionals to utilise social media to provide personalised care is abundant and with mobile devices becoming increasingly prolific, this personal contact is fast becoming continuous. Media is no longer simply a tool for companies to broadcast their own message, but has transformed into a means in which pharma are able to provide round the clock care, through active monitoring and remote diagnosis.

Join our panel of leading industry speakers, from Big Pharma companies to cutting edge developers at the heart of social media technology today. You simply cannot afford to miss out.

Reasons to Attend:

Learn about the cutting edge developments in social media including personalised marketing techniques, mobile platforms, remote monitoring and open stakeholder engagement.

Share ideas with leading technology providers; discuss the industry requirements and learn what technological solutions are available.

Hear how major pharmaceutical companies are actually applying the latest developments in social media in a practical way.

Analyse how social media will allow your organisation to better communicate and interact with your stakeholders.

Expert Speaker Line-up includes:

Doris Cesares, Director of Communication, AESEG

Sherri Matis-Mitchell, R and D, Astra Zeneca 

Neeraj Goel Mittal, Business Intelligence Manager, AbbVie 

Dr. Alfred R. Steinhardt, Founder, Alfred Steinhardt Consulting

Piotr Wrzosinski, Digital Marketing, Roche 

Ben Furber, Asthma UK

Claire Perrin, European Brand Leader, Eli Lilly

Alexandra Fulford, Consultant, Pharmaguapa 

Gizem Bicakci, eMarketing, Boehringer-Ingelheim 

Matt Evans, Chief Medical Officer, Health Unlocked 

Todd Kolm, Vice-President, Head of Global Digital Strategy, Sanofi

James Finney, Project Manager, Global Comm. Services, Novozymes Biopharma

Shona Davies, Communication and Programme Leader, Merck

For further details and to register, visit http://www.smi-online.co.uk/goto/2014social-media-pharma26.asp 

Alternatively contact John Collins on +44 (0)20 7827 6000 or email jcollins@smi-online.co.uk 

Join the conversation on Twitter @smigrouppharm | #pharmasocialmedia



Further information
Scientific News
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Reprogramming Scorpion Venom
‘Twist of nature’ neutralizes toxin.
Tailoring a Suit for Tumor-Penetrating Cancer Meds
For more than a decade, biomedical researchers have been looking for better ways to deliver cancer-killing medication directly to tumors in the body.
Resurrecting an Abandoned Drug
Previously discarded drug shows promise in helping human cells in a lab dish fight off two different viruses.
Safer, Cheaper, Greener and More Efficient System for Organic Synthesis
The new medium not only supports organic synthesis it also produces considerably higher yields of product than pure organic solvents.
Fighting Prostate Cancer
Identifying the most promising compounds which can be used as medications for prostate cancer.
Collaboration to Develop Cancer Therapeutics
Major license agreement with Merck, enabled by Blavatnik Biomedical Accelerator, aims to develop therapy for most common form of acute leukemia.
Faster UVA Molecular Analysis Technology
There are people in the world – chemical engineers, astronomers, national defense scientists investigating an explosion – who need to know just what something is made of, down to the molecular level.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!